Company Name:

Jay Pharma is dedicated to developing innovative, evidence-based cannabinoid medicines and combination therapies to address unmet needs in cancer care. Our mission is to improve the lives of persons suffering from cancer, initially by developing over-the-counter products for persons suffering from the side effects of cancer and cancer treatments, and longer term by advancing a pipeline of novel combination therapies as an adjunct to standard of care cancer treatments. Jay Pharma plans to initiate exploratory clinical studies in hard-to-treat conditions that include glioblastoma multiforme, triple-negative breast cancer, pancreatic cancer, and acute myeloid leukemia. As the first cannabinoid pharmaceutical company focused exclusively on cancer, Jay Pharma brings leading oncology clinicians and researchers, academic and industry partners, proprietary products and data, and a robust pipeline of drug candidates.

Contact Information